Fucoidan–Fucoxanthin Ameliorated Cardiac Function via IRS1/GRB2/ SOS1, GSK3β/CREB Pathways and Metabolic Pathways in Senescent Mice

The effects of low molecular weight fucoidan (LMWF) in combination with high-stability fucoxanthin (HSFUCO) on cardiac function and the metabolic pathways of aging mice (Mus musculus) were investigated. We demonstrated that LMWF and HSFUCO could improve cardiac function in aging mice. Aging mice were treated with LMWF and HSFUCO, either on their own or in combination, on 28 consecutive days. Electrocardiography and whole-cell patch-clamp were used to measure QT interval and action potential duration (APD) of the subjects. Cardiac tissue morphology, reactive oxygen species, and Western blot were also applied. Ultra-high-performance liquid chromatography–quadrupole time-of-flight (UPLC-QTOF) mass spectrometry was used for investigating metabolic alterations. The use of LMWF and HSFUCO resulted in improvements in both ventricular rhythms (QT and APD). Treatment with fucoidan and fucoxanthin reduced the expression levels of SOS1 and GRB2 while increasing GSK3β, CREB and IRS1 proteins expression in the aging process. Three main metabolic pathways, namely the TCA cycle, glycolysis, and steroid hormone biosynthesis, were highly enriched in the pathway enrichment analysis. When taken together, the LMWF and HSFUCO treatment improved both the ventricular rhythm and the muscular function of aging subjects by interfering with the metabolism and gene function.

Download Full-text

Serum metabolic profiles changes observed post COVID-19 – Case report

Journal of Clinical Images and Medical Case Reports ◽

10.52768/2766-7820/1326 ◽

2021 ◽

Vol 2 (5) ◽

Author(s):

Beata Toczylowska ◽

◽

Anna Slowikowska ◽

Elzbieta Zieminska ◽

◽

...

Keyword(s):

Nmr Spectroscopy ◽

Metabolic Pathways ◽

Cholesterol Metabolism ◽

Tca Cycle ◽

Metabolic Profiles ◽

Blood Tests ◽

The Tca Cycle ◽

Metabolite Profiles ◽

Long Time ◽

Hormone Biosynthesis

COVID-19 and its consequences are still not well known. The recovery from the infection is slow and many symptoms persist for a long time. We present the influence of the SARS-CoV-2 infection on serum metabolic profiles. The profiles were obtained using NMR spectroscopy from sera collected two years prior to the infection and twice during the recovery time from otherwise healthy subject. We performed comparisons of data collected pre- with postinfection. We present the metabolites which levels were decreased after COVID-19. These metabolites are involved in metabolic pathways like the TCA cycle, purine, glycine, arginine, proline, pyruvate, taurine, alanine, glutamate, glycerophospholipids, and cholesterol metabolism, as well as fatty acid and steroid hormone biosynthesis. Studies show changes in metabolic profiles during the recovery after COVID-19 that have not been observed by standard blood tests. Keywords: COVID-19; NMR spectroscopy; serum metabolite profiles.

Download Full-text

The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells

Cells ◽

10.3390/cells10040762 ◽

2021 ◽

Vol 10 (4) ◽

pp. 762

Author(s):

Edward V. Prochownik ◽

Huabo Wang

Keyword(s):

Metabolic Pathways ◽

Redox State ◽

Pyruvate Dehydrogenase Complex ◽

Tca Cycle ◽

Vascular Supply ◽

Extrinsic Factors ◽

The Tca Cycle ◽

Initial Substrate ◽

Numerous Cell ◽

Bio Synthesis

Pyruvate occupies a central metabolic node by virtue of its position at the crossroads of glycolysis and the tricarboxylic acid (TCA) cycle and its production and fate being governed by numerous cell-intrinsic and extrinsic factors. The former includes the cell’s type, redox state, ATP content, metabolic requirements and the activities of other metabolic pathways. The latter include the extracellular oxygen concentration, pH and nutrient levels, which are in turn governed by the vascular supply. Within this context, we discuss the six pathways that influence pyruvate content and utilization: 1. The lactate dehydrogenase pathway that either converts excess pyruvate to lactate or that regenerates pyruvate from lactate for use as a fuel or biosynthetic substrate; 2. The alanine pathway that generates alanine and other amino acids; 3. The pyruvate dehydrogenase complex pathway that provides acetyl-CoA, the TCA cycle’s initial substrate; 4. The pyruvate carboxylase reaction that anaplerotically supplies oxaloacetate; 5. The malic enzyme pathway that also links glycolysis and the TCA cycle and generates NADPH to support lipid bio-synthesis; and 6. The acetate bio-synthetic pathway that converts pyruvate directly to acetate. The review discusses the mechanisms controlling these pathways, how they cross-talk and how they cooperate and are regulated to maximize growth and achieve metabolic and energetic harmony.

Download Full-text

Identification of novel cardiovascular disease associated metabolites using untargeted metabolomics

Biological Chemistry ◽

10.1515/hsz-2020-0331 ◽

2021 ◽

Vol 0 (0) ◽

Author(s):

Shams Tabrez ◽

Mohammed Razeeth Shait Mohammed ◽

Nasimudeen R. Jabir ◽

Mohammad Imran Khan

Keyword(s):

Cardiovascular Disease ◽

Metabolic Pathways ◽

Enrichment Analysis ◽

Pathway Enrichment Analysis ◽

Healthy Individuals ◽

Great Opportunity ◽

Pathway Enrichment ◽

Pathophysiological Role ◽

The World ◽

Metabolomic Approach

Abstract Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality around the world. Early diagnosis of CVD could provide the opportunity for sensible management and better clinical outcome along with the prevention of further progression of the disease. In the current study, we used an untargeted metabolomic approach to identify possible metabolite(s) that associate well with the CVD and could serve either as therapeutic target or disease-associated metabolite. We identified 26 rationally adjusted unique metabolites that were differentially present in the serum of CVD patients compared with healthy individuals, among them 15 were found to be statistically significant. Out of these metabolites, we identified some novel metabolites like UDP-l-rhamnose and N1-acetylspermidine that have not been reported to be linked with CVD directly. Further, we also found that some metabolites like ethanolamide, solanidine, dimethylarginine, N-acetyl-l-tyrosine, can act as a discriminator of CVD. Metabolites integrating pathway enrichment analysis showed enrichment of various important metabolic pathways like histidine metabolism, methyl histidine metabolism, carnitine synthesis, along with arginine and proline metabolism in CVD patients. Our study provides a great opportunity to understand the pathophysiological role and impact of the identified unique metabolites and can be extrapolated as specific CVD specific metabolites.

Download Full-text

Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance

Cancers ◽

10.3390/cancers13112634 ◽

2021 ◽

Vol 13 (11) ◽

pp. 2634

Author(s):

Beatriz Soldevilla ◽

Angeles López-López ◽

Alberto Lens-Pardo ◽

Carlos Carretero-Puche ◽

Angeles Lopez-Gonzalvez ◽

...

Keyword(s):

Metabolic Pathways ◽

Metabolic Networks ◽

Tca Cycle ◽

Metabolomic Profile ◽

Diagnostic Potential ◽

The Tca Cycle ◽

Novel Biomarkers ◽

Potential Methods ◽

Clinical Potential ◽

First Time

Purpose: High-throughput “-omic” technologies have enabled the detailed analysis of metabolic networks in several cancers, but NETs have not been explored to date. We aim to assess the metabolomic profile of NET patients to understand metabolic deregulation in these tumors and identify novel biomarkers with clinical potential. Methods: Plasma samples from 77 NETs and 68 controls were profiled by GC−MS, CE−MS and LC−MS untargeted metabolomics. OPLS-DA was performed to evaluate metabolomic differences. Related pathways were explored using Metaboanalyst 4.0. Finally, ROC and OPLS-DA analyses were performed to select metabolites with biomarker potential. Results: We identified 155 differential compounds between NETs and controls. We have detected an increase of bile acids, sugars, oxidized lipids and oxidized products from arachidonic acid and a decrease of carnitine levels in NETs. MPA/MSEA identified 32 enriched metabolic pathways in NETs related with the TCA cycle and amino acid metabolism. Finally, OPLS-DA and ROC analysis revealed 48 metabolites with diagnostic potential. Conclusions: This study provides, for the first time, a comprehensive metabolic profile of NET patients and identifies a distinctive metabolic signature in plasma of potential clinical use. A reduced set of metabolites of high diagnostic accuracy has been identified. Additionally, new enriched metabolic pathways annotated may open innovative avenues of clinical research.

Download Full-text

Effects of corn steep liquor on β-poly(l-malic acid) production in Aureobasidium melanogenum

AMB Express ◽

10.1186/s13568-020-01147-8 ◽

2020 ◽

Vol 10 (1) ◽

Author(s):

Genan Wang ◽

Bingyi Shi ◽

Pan Zhang ◽

Tingbin Zhao ◽

Haisong Yin ◽

...

Keyword(s):

Malic Acid ◽

Low Cost ◽

Corn Steep Liquor ◽

Enrichment Analysis ◽

Tca Cycle ◽

Water Soluble ◽

Growth And Yield ◽

The Tca Cycle ◽

Steep Liquor ◽

Aureobasidium Melanogenum

Abstractβ-poly(l-malic acid) (PMLA) is a water-soluble biopolymer used in medicine, food, and other industries. However, the low level of PMLA biosynthesis in microorganisms limits its further application in the biotechnological industry. In this study, corn steep liquor (CSL), which processes high nutritional value and low-cost characteristics, was selected as a growth factor to increase the PMLA production in strain, Aureobasidium melanogenum, and its metabolomics change under the CSL addition was investigated. The results indicated that, with 3 g/L CSL, PMLA production, cell growth, and yield (Yp/x) were increased by 32.76%, 41.82%, and 47.43%, respectively. The intracellular metabolites of A. melanogenum, such as amino acids, organic acids, and key intermediates in the TCA cycle, increased after the addition of CSL, and the enrichment analysis showed that tyrosine may play a major role in the PMLA biosynthesis. The results presented in this study demonstrated that the addition of CSL would be an efficient approach to improve PMLA production.

Download Full-text

Intracellular Fate of Universally Labelled 13C Isotopic Tracers of Glucose and Xylose in Central Metabolic Pathways of Xanthomonas oryzae

Metabolites ◽

10.3390/metabo8040066 ◽

2018 ◽

Vol 8 (4) ◽

pp. 66 ◽

Cited By ~ 4

Author(s):

Manu Shree ◽

Shyam K. Masakapalli

Keyword(s):

Amino Acids ◽

Metabolic Pathways ◽

Metabolic Networks ◽

Tca Cycle ◽

Xanthomonas Oryzae ◽

Flux Analysis ◽

Isotopic Tracers ◽

Feeding Experiments ◽

The Tca Cycle ◽

Metabolic Route

The goal of this study is to map the metabolic pathways of poorly understood bacterial phytopathogen, Xanthomonas oryzae (Xoo) BXO43 fed with plant mimicking media XOM2 containing glutamate, methionine and either 40% [13C5] xylose or 40% [13C6] glucose. The metabolic networks mapped using the KEGG mapper and the mass isotopomer fragments of proteinogenic amino acids derived from GC-MS provided insights into the activities of Xoo central metabolic pathways. The average 13C in histidine, aspartate and other amino acids confirmed the activities of PPP, the TCA cycle and amino acid biosynthetic routes, respectively. The similar labelling patterns of amino acids (His, Ala, Ser, Val and Gly) from glucose and xylose feeding experiments suggests that PPP would be the main metabolic route in Xoo. Owing to the lack of annotated gene phosphoglucoisomerase in BXO43, the 13C incorporation in alanine could not be attributed to the competing pathways and hence warrants additional positional labelling experiments. The negligible presence of 13C incorporation in methionine brings into question its potential role in metabolism and pathogenicity. The extent of the average 13C labelling in several amino acids highlighted the contribution of pre-existing pools that need to be accounted for in 13C-flux analysis studies. This study provided the first qualitative insights into central carbon metabolic pathway activities in Xoo.

Download Full-text

Identification of Urine Metabolic Biomarkers for Vogt-Koyanagi-Harada Disease

Frontiers in Cell and Developmental Biology ◽

10.3389/fcell.2021.637489 ◽

2021 ◽

Vol 9 ◽

Author(s):

Rui Chang ◽

Ying Zhu ◽

Jing Xu ◽

Lin Chen ◽

Guannan Su ◽

...

Keyword(s):

High Performance ◽

Area Under The Curve ◽

Enrichment Analysis ◽

Pathway Enrichment Analysis ◽

Healthy Controls ◽

Roc Curve Analysis ◽

Multivariate Statistical ◽

Flight Mass Spectrometry ◽

Laboratory Biomarkers ◽

Vkh Disease

The diagnosis of Vogt-Koyanagi-Harada (VKH) disease is mainly based on a complex clinical manifestation while it lacks objective laboratory biomarkers. To explore the potential molecular biomarkers for diagnosis and disease activity in VKH, we performed an untargeted urine metabolomics analysis by ultra-high-performance liquid chromatography equipped with quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF/MS). Through univariate and multivariate statistical analysis, we found 9 differential metabolites when comparing VKH patients with healthy controls, and 26 differential metabolites were identified when comparing active VKH patients with inactive VKH patients. Pathway enrichment analysis showed that glycine, serine and threonine metabolism, and arginine and proline metabolism were significantly altered in VKH versus healthy controls. Lysine degradation and biotin metabolism pathways were significantly altered in active VKH versus inactive VKH. Furthermore, the receiver operating characteristic (ROC) curve analysis revealed that the combination of acetylglycine and gamma-glutamylalanine could differentiate VKH from healthy controls with an area under the curve (AUC) of 0.808. A combination of ureidopropionic acid and 5′-phosphoribosyl-5-amino-4-imidazolecarboxamide (AICAR) had an excellent AUC of 0.958 for distinguishing active VKH from inactive VKH. In summary, this study identified abnormal metabolites in urine of patients with VKH disease. Further studies are needed to confirm whether these metabolites are specific for this disease.

Download Full-text

Metabolic Constants and Plasticity of Cancer Cells in a Limiting Glucose and Glutamine Microenvironment—A Pyruvate Perspective

Frontiers in Oncology ◽

10.3389/fonc.2020.596197 ◽

2020 ◽

Vol 10 ◽

Author(s):

Angela M. Otto

Keyword(s):

Cancer Cells ◽

Metabolic Network ◽

Metabolic Pathways ◽

Cancer Cell Line ◽

Tca Cycle ◽

Reaction Rates ◽

Diagnostic Methods ◽

Metabolic Reprogramming ◽

Amino Acid Synthesis ◽

The Tca Cycle

The metabolism of cancer cells is an issue of dealing with fluctuating and limiting levels of nutrients in a precarious microenvironment to ensure their vitality and propagation. Glucose and glutamine are central metabolites for catabolic and anabolic metabolism, which is in the limelight of numerous diagnostic methods and therapeutic targeting. Understanding tumor metabolism in conditions of nutrient depletion is important for such applications and for interpreting the readouts. To exemplify the metabolic network of tumor cells in a model system, the fate 13C6-glucose was tracked in a breast cancer cell line growing in variable low glucose/low glutamine conditions. 13C-glucose-derived metabolites allowed to deduce the engagement of metabolic pathways, namely glycolysis, the TCA-cycle including glutamine and pyruvate anaplerosis, amino acid synthesis (serine, glycine, aspartate, glutamate), gluconeogenesis, and pyruvate replenishment. While the metabolic program did not change, limiting glucose and glutamine supply reduced cellular metabolite levels and enhanced pyruvate recycling as well as pyruvate carboxylation for entry into the TCA-cycle. Otherwise, the same metabolic pathways, including gluconeogenesis, were similarly engaged with physiologically saturating as with limiting glucose and glutamine. Therefore, the metabolic plasticity in precarious nutritional microenvironment does not require metabolic reprogramming, but is based on dynamic changes in metabolite quantity, reaction rates, and directions of the existing metabolic network.

Download Full-text

Metabolomic Links Between Sweetened Beverage Intake and Obesity (OR31-05-19)

Current Developments in Nutrition ◽

10.1093/cdn/nzz037.or31-05-19 ◽

2019 ◽

Vol 3 (Supplement_1) ◽

Author(s):

Chao-Qiang Lai ◽

Reiko Ichikawa ◽

Bingjie Zhou ◽

Laurence Parnell ◽

Sabrina Noel ◽

...

Keyword(s):

Genetic Variants ◽

Metabolic Pathways ◽

Enrichment Analysis ◽

Health Study ◽

Pathway Enrichment Analysis ◽

Linear Regression Models ◽

Obesity Risk ◽

Pathway Enrichment ◽

Sweetened Beverage ◽

Increased Risk

Abstract Objectives Sweetened beverage (SB) consumption is highly associated with obesity, but the mechanism underlying this correlation is not understood. Our objective was to examine metabolomic links between SB intake and obesity to understand metabolic mechanisms. Methods We examined the association of plasma metabolomic profiles with SB intake and obesity risk in 782 participants, aged 45–75y, in the Boston Puerto Rican Health Study (BPRHS) using linear regression models, controlling for potential confounding factors. Based on identified metabolites, we conducted pathway enrichment analysis to identify potential metabolic pathways that link SB intake and obesity risk. Genetic variants in identified metabolic pathways were examined for their interaction with SB intake on metabolites of interest and obesity. Interactions between SB and genotypes on obesity were evaluated for replication in the Framingham Heart Study (FHS). Results In BPRHS, SB intake was highly correlated with BMI (β = 0.455, P < 0.05). Among 526 measurable metabolites, 109 metabolites showed significant correlation with SB intake and 170 metabolites with BMI (P < 0.05); and 43 were correlated with both SB intake and BMI. Pathway enrichment analysis identified two metabolic pathways: phosphatidylethanolamine (PE) and lysophospholipid pathways linking SB intake and obesity, after correction for multiple testing. Focusing on the PE pathway, we identified 12 SNPs in nine genes that were significantly associated with BMI. At least four genetic variants showed suggestive interaction with SB intake on obesity risk and obesity-associated metabolites. In particular, CC carriers of rs4646360 in the PEMT (Phosphatidylethanolamine N-Methyltransferase) gene had increased risk of obesity when consuming SB. We replicated this finding in the FHS study. Conclusions We identified two key metabolic pathways linking SB intake to obesity, revealing potential mechanisms by which SB intake increases the risk of obesity. The interaction between genetic variants in the identified pathway and SB intake on obesity and obesity-associated metabolites further supports the mechanism. Funding Sources This work was funded by the US Department of Agriculture, under agreement no. 8050-51,000-098-00D, and NIH grants P01 AG023394, P50 HL105185, and R01 AG027087.

Download Full-text

Fast in vivo detection of myocardial norepinephrine levels in the beating porcine heart

AJP Heart and Circulatory Physiology ◽

10.1152/ajpheart.00574.2019 ◽

2020 ◽

Vol 318 (5) ◽

pp. H1091-H1099 ◽

Cited By ~ 2

Author(s):

Shyue-An Chan ◽

Marmar Vaseghi ◽

Nicholas Kluge ◽

Kalyanam Shivkumar ◽

Jeffrey L. Ardell ◽

...

Keyword(s):

Cardiac Function ◽

Temporal Resolution ◽

High Performance ◽

Cardiac Tissue ◽

Enzyme Linked Immunosorbent Assay ◽

High Temporal Resolution ◽

Sample Collection ◽

Significant Information ◽

Porcine Heart

The sympathetic nervous system modulates cardiac function by controlling key parameters such as chronotropy and inotropy. Sympathetic control of ventricular function occurs through extrinsic innervation arising from the stellate ganglia and thoracic sympathetic chain. In the healthy heart, sympathetic release of norepinephrine (NE) results in positive modulation of chronotropy, inotropy, and dromotropy, significantly increasing cardiac output. However, in the setting of myocardial infarction or injury, sympathetic activation persists, contributing to heart failure and increasing the risk of arrhythmias, including sudden cardiac death. Methodologies for detection of norepinephrine in cardiac tissue are limited. Present techniques rely on microdialysis for analysis by high-performance liquid chromatography coupled to electrochemical detection (HPLC-ED), radioimmunoassay, or other immunoassays, such as enzyme-linked immunosorbent assay (ELISA). Although significant information about the release and action of norepinephrine has been obtained with these methodologies, they are limited in temporal resolution, require large sample volumes, and provide results with a significant delay after sample collection (hours to weeks). In this study, we report a novel approach for measurement of interstitial cardiac norepinephrine, using minimally invasive, electrode-based, fast-scanning cyclic voltammetry (FSCV) applied in a beating porcine heart. The first multispatial and high temporal resolution, multichannel measurements of NE release in vivo are provided. Our data demonstrate rapid changes in interstitial NE profiles with regional differences in response to coronary ischemia, sympathetic nerve stimulation, and alterations in preload/afterload. NEW & NOTEWORTHY Pharmacological, electrical, or surgical regulation of sympathetic neuronal control can be used to modulate cardiac function and treat arrhythmias. However, present methods for monitoring sympathetic release of norepinephrine in the heart are limited in spatial and temporal resolution. Here, we provide for the first time a methodology and demonstration of practice and rapid measures of individualized regional autonomic neurotransmitter levels in a beating heart. We show dynamic, spatially resolved release profiles under normal and pathological conditions.

Download Full-text